Search

everythinglearnresearchcommunity

for

Search:↓

Exogenous testosterone use may be linked to developing hidradenitis suppurativa.

Anti-androgen therapy may boost immunity but increases injection site pain in vaccinated patients.

No clear link between androgenetic alopecia and COVID-19 was found.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Long-haul COVID can cause lasting symptoms affecting many body systems and may be linked to ongoing inflammation and immune system issues.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

Older adults diagnosed with lupus show less severe symptoms but have a lower survival rate, often due to age-related factors.

Many patients experience long-lasting symptoms like fatigue and pain after COVID-19, regardless of initial disease severity.

COVID-19 can cause over 50 long-term symptoms, with fatigue and headache being the most common.

Nanotechnology shows promise for better chronic wound healing but needs more research.

People with Birt-Hogg-Dubé syndrome often have lung problems and delayed diagnosis, and better recognition of CT scan signs could improve diagnosis and management.

Targeting TGFβ can improve skin immunity in older people.

Sumatriptan injections, high-flow oxygen, and verapamil effectively treat cluster headaches.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

New treatments for COVID-19 show promise, but more effective antiviral drugs are needed.

Some skin conditions, like psoriasis and early-onset baldness, may indicate metabolic syndrome, and others are linked to diabetes risk and cardiovascular issues.

Women may need different blood pressure guidelines than men for heart disease prevention.

The conclusion is that women under 35 should start fertility checks after 12 months of trying to conceive, women over 35 after 6 months, and women over 40 should start immediately. The checks should include ovulation status, reproductive tract structure, and male partner's semen evaluation.

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

Gene therapy shows promise for healing chronic wounds but needs more research to overcome challenges.

Insulin resistance and high male hormone levels are major causes of Polycystic Ovary Syndrome.

Direct vasodilators and sympatholytic agents are still useful for certain conditions despite being less common due to side effects and newer drugs.

Searches for acne, hair loss, and eczema increased during COVID-19, while searches for other skin issues decreased.

SLE patients in eastern Saudi Arabia have a generally good prognosis despite multi-organ involvement.

Genetic variations greatly affect individual metabolism and can impact health and disease risk.

Scalp inflammation can cause multiple hairs to grow from one follicle.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.